FdaApplication

NDA 211448

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCMG PHARMACEUTICAL CO LTD
application_typeNDA
approval_date2025-04-15

Products (3)

ProductActive ingredientStrengthDosage form
MEZOFYARIPIPRAZOLE15MGFILM;ORAL
MEZOFYARIPIPRAZOLE10MGFILM;ORAL
MEZOFYARIPIPRAZOLE5MGFILM;ORAL

3 products